ClinicalTrials.gg

Program

JNJ-78934804

A development code.

Its studies are mostly in Colitis, Ulcerative · Crohn Disease, led by Johnson & Johnson.

Furthest: phase 3, since May 5, 20264 company-led studies, 4 open or runningNext primary completion: Jun 12, 2028 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Johnson & Johnson44 open or runningphase 3since May 5, 2026Feb 15, 2022Jun 12, 2028phase 3 · NCT07577843

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Feb 15, 2022First studies: 2 phase 2 studiesFirst studyNCT05242484, NCT05242471
  2. May 5, 20262 phase 3 studiesPhase 3 reachedNCT07577856, NCT07577843

Ahead

  1. Jun 12, 2028Primary completion: phase 3 study in Crohn DiseaseNCT07577843
  2. Aug 11, 2028Primary completion: phase 3 study in Colitis, UlcerativeNCT07577856

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 4 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07577856Colitis, Ulcerative · United States, Argentina, Australia and more3RecruitingAug 11, 2028644
NCT07577843Crohn Disease · United States, Argentina, Australia and more3RecruitingJun 12, 2028460
NCT05242484Colitis, Ulcerative · United States, Argentina, Australia and more2Active, not recruitingMay 15, 2025577
NCT05242471Crohn Disease · United States, Australia, Austria and more2Active, not recruitingMay 23, 2025703

How it is read

Names in the registry

  • “JNJ-78934804”, 4 entries

Codes read as this program: JNJ78934804.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.